The National People's Congress (NPC) Standing Committee, China's top legislature, on Wednesday launched a nationwide inspection of the enforcement of the Pharmaceutical Administration Law.
Four teams of senior lawmakers will conduct inspections from late March to early May in eight provincial regions, including Beijing Municipality, and the provinces of Heilongjiang, Jiangsu, Anhui, Shandong, Hunan, Sichuan and Yunnan, according to a meeting about the inspection.
The inspection will focus on the formulation of supporting laws, regulations and rules, the development of drug regulation systems, and the supply of common clinical drugs and drugs for rare diseases, among others.
The NPC Standing Committee will review a report on inspection results in late June.
